These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4912137)

  • 21. Recognition and management of neonatal sepsis.
    Forgey CJ; Adamkin DH
    J Ky Med Assoc; 1980 Dec; 78(12):726-9. PubMed ID: 7003038
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dynamics of sensitivity to antibiotics of causative agents of colienteritis in infants during 1959-1969 (based on data from the Hospital for Infectious Diseases)].
    Garanin BA
    Antibiotiki; 1971 Jan; 16(1):90-1. PubMed ID: 4928598
    [No Abstract]   [Full Text] [Related]  

  • 23. [Colimycin therapy of Escherichia coli dyspepsia in infants].
    SACREZ R; LEVY JM; MINCK R
    Minerva Med; 1958 Dec; 49(97):4504-8. PubMed ID: 13622335
    [No Abstract]   [Full Text] [Related]  

  • 24. [A study of comparative effectiveness of polymyxin M and monomycin in the treatment of children with intestinal coli infection].
    Khodalevich IV
    Vopr Okhr Materin Det; 1968 Dec; 13(12):68-9. PubMed ID: 4310046
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis by immuno-fluorescence in a toxico-septic syndrome after the beginning of treatment with antibiotics].
    Georgesco C
    Arch Roum Pathol Exp Microbiol; 1966 Sep; 25(3):611-6. PubMed ID: 5341619
    [No Abstract]   [Full Text] [Related]  

  • 26. An unusual case of dramatic acute bilateral pyelonephritis with systemic bacterial dissemination caused by uropathogenic Escherichia coli.
    Khouri N; de Beauregard MA; Tassart M; Callard P; Verdet C; Rossier A; Elbim C; Gougerot-Pocidalo MA; Le Bouguénec C; Rondeau E; Vandewalle A
    Nephrol Dial Transplant; 2006 May; 21(5):1423-6. PubMed ID: 16431892
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the current status of the treatment for dyspepsia coli infections].
    Lässker G; Breidenbach H
    Dtsch Gesundheitsw; 1965 Sep; 20(36):1679-81. PubMed ID: 5324981
    [No Abstract]   [Full Text] [Related]  

  • 28. Reevaluating antibiotic therapy for urinary tract infections in children.
    Yared A; Edwards KM
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):992-3. PubMed ID: 16203947
    [No Abstract]   [Full Text] [Related]  

  • 29. Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Blot S; Vandijck D; Vandewoude K; Depuydt P; Vogelaers D; Peleman R
    J Antimicrob Chemother; 2007 Dec; 60(6):1402. PubMed ID: 17913718
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple and effective approach for the treatment of chronic wound infections caused by multiple antibiotic resistant Escherichia coli.
    Nagoba BS; Wadher BJ; Rao AK; Kore GD; Gomashe AV; Ingle AB
    J Hosp Infect; 2008 Jun; 69(2):177-80. PubMed ID: 18485531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in pathogenesis of diarrheal disease relation to treatment and prevention.
    Pierce NF
    Paediatr Indones; 1972 Nov; 12(11):479-83. PubMed ID: 4601107
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.
    Butler CC; Hillier S; Roberts Z; Dunstan F; Howard A; Palmer S
    Br J Gen Pract; 2006 Sep; 56(530):686-92. PubMed ID: 16954001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.
    Raum E; Lietzau S; von Baum H; Marre R; Brenner H
    Clin Microbiol Infect; 2008 Jan; 14(1):41-8. PubMed ID: 18005177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute gastroenteritis caused by enterohemorrhagic E. coli O157:H7].
    Weinberger T; Hayek T; Keidar S
    Harefuah; 1998 May; 134(10):767-9, 831. PubMed ID: 10909634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
    Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferable antibiotic resistance in Escherichia coli.
    Datta N
    Proc R Soc Med; 1971 May; 64(5):533-4. PubMed ID: 4930727
    [No Abstract]   [Full Text] [Related]  

  • 39. [CONTRIBUTION ON THE PREVENTION OF INTESTINAL INFECTIONS IN INFANTS CAUSED BY E. COLI].
    GYERGYAI K; PALL G
    Gyermekgyogyaszat; 1963 Oct; 14():289-97. PubMed ID: 14054330
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.